Omicron threat: Three doses of Pfizer-BioNTech COVID-19 vaccine neutralises new variant, says study
BioNTech and Pfizer said that a preliminary laboratory study demonstrated a three-shot course of their COVID-19 vaccine generates a neutralising effect against the new Omicron variant in a laboratory test.
Dec 09, 2021, 06:30 AM IST
Documents for emergency use listing of Covaxin submitted to WHO, says Bharat Biotech
A WHO pre-qualification, or a EUL, is necessary for a vaccine company to supply vaccines for global facilities such as Covax or international procurement.
Jul 13, 2021, 07:19 AM IST
Get Pfizer or Moderna for second dose after receiving AstraZeneca vaccine, suggests NACI
Canada`s National Advisory Committee on Immunizations (NACI) said that those who received the first shot of Oxford-AstraZeneca in their vaccination schedule can get vaccinated with a messenger RNA (mRNA) vaccine for their second dose.
Jun 18, 2021, 09:37 AM IST
UK launches 3rd booster dose trial of 7 COVID vax
In a first, the UK has launched a new clinical trial that will assess the efficacy of a third 'booster' dose of seven different COVID-19 vaccines on patients' immune responses, the media reported.
May 23, 2021, 16:17 PM IST
